|
|||||||||||
 |
|||||||||||
|
|||||||||||
Top Stories
Immunize.org Website and Clinical Resources
Featured Resources
Notable Publications
Upcoming Events
Top Stories
Large U.S. study of nirsevimab (Beyfortus, Sanofi) shows high real-world effectiveness in protecting infants against RSV-associated respiratory disease
In its July 22 issue, Pediatrics published Effectiveness of Nirsevimab Against RSV and RSV-Related Events in Infants, including a video abstract. Nirsevimab (Beyfortus, Sanofi) preventive antibody product demonstrated strong effectiveness in protecting infants against RSV. Infants who received nirsevimab and still developed RSV disease had fewer medical visits and hospitalizations compared to those who were not immunized. RSV hospitalizations fell by 98% compared to unimmunized infants. The study excluded infants whose mothers received RSV vaccine during pregnancy to clearly measure nirsevimab’s effect. Portions of the abstract appear below. Plan now to ensure all eligible infants age 8 months and younger receive nirsevimab when its use resumes in October. Back to top
New! CDC releases at-a-glance resources for RSV products to help you prepare for respiratory virus season. The CDC released four new at-a-glance resources for healthcare professionals on RSV prevention products. Each 2-page document addresses a single product. Use these resources to help your clinical team prepare for RSV prevention in adults and infants this fall. These materials are available on the CDC’s main Respiratory Syncytial Virus (RSV) Immunizations main page and include the following documents:
On July 23, the HHS secretary accepted the ACIP recommendation for the use of 2025–26 seasonal influenza vaccines that do not contain thimerosal as a preservative. The HHS decision follows the June 26 ACIP vote. CDC’s “Thimerosal and Vaccines” web page currently states: “There is no evidence of harm caused by the low doses of thimerosal in vaccines, except for minor reactions like redness and swelling at the injection site.” Only about 4–5% of seasonal influenza vaccine doses administered in the most recent influenza season came from preservative-containing multidose vials.
Related Links
National Immunization Awareness Month starts August 1. Use these resources to encourage vaccination. August is National Immunization Awareness Month (NIAM). This annual observance highlights the importance of protecting people of all ages against vaccine-preventable diseases through on-time vaccination. This year, NIAM serves as a focal point to share trustworthy, credible information about the importance of staying up to date with routine immunizations.
Confirmed measles cases in 2025 increase to 1,319 across 39 states; public health officials urge vaccination
As of July 23, CDC reported 1,319 confirmed measles cases in 2025 in 39 states. Among confirmed cases of all ages, 13% were hospitalized. Among those younger than age 5 years, 29% were hospitalized.
Immunize.org offers measles-related resources for the public on several of our affiliated websites:
Another credible source is the American Academy of Pediatrics’ website for parents on measles.  Related Links
"Will Adults Need Additional Pneumococcal Conjugate Vaccines in the Future?” Watch the 1-minute answer, part of the Ask the Experts Video Series on YouTube. This week, our featured episode from the Ask the Experts Video Series is titled Will Adults Need Additional Pneumococcal Conjugate Vaccines in the Future? The video briefly explains that those vaccinated against pneumococcal disease at younger ages may eventually be recommended to receive a future PCV dose to sustain protection later in life. Like, follow, and share Immunize.org’s social media accounts and encourage colleagues and others interested in vaccination to do likewise.
These recent articles convey the potential risks of vaccine-preventable diseases and the importance of vaccination.
Immunize.org Website and Clinical Resources
Do you ever need to locate vaccine-related communications or announcements from ACIP, CDC, or FDA? Immunize.org gathers them in our Official Release Repository web page within the "News & Updates" menu atop each page.
 Featured Resources
What vaccinators are sporting during National Immunization Awareness Month, from the Immunize.org shop!
The Immunize.org Shop offers a variety of products for your practice and to show how much you value vaccination. These may be especially helpful as you observe National Immunization Awareness Month in August.
 Visit Shop Immunize.org to view pricing information and to place an order. For more information, call 651-647-9009 or email [email protected]. Notable Publications
“Change in Influenza Vaccine Uptake Among Adults in the United States from May 2020 to October 2024” published in PLOS Global Public Health
In its July 16 issue, PLOS Global Public Health published Change in Influenza Vaccine Uptake Among Adults in the United States from May 2020 to October 2024. The study shows a concerning reduction in influenza vaccination during this period among people typically associated with higher vaccine uptake. A portion of the abstract appears below. Back to top
In its July 17 issue, Pediatrics published Disparities in Nirsevimab Uptake Across a Pediatric Primary Care Network, including a video abstract. The article highlights wide variation among 32 pediatric practices in use of nirsevimab (Beyfortus, Sanofi) among infants born between April and August before their first RSV season. These results show the importance of using reminder-recall and other clinic workflow strategies to improve timely immunization of eligible infants born in late spring and summer. Portions of the abstract appear below. Upcoming Events NFID hosts webinar titled “Communication Strategies to Build Trust and Address Misinformation” on August 6 at 2:00 p.m. (ET); CE credit offered
NFID will host a webinar titled Communication Strategies to Build Trust and Address Misinformation at 2:00 p.m. (ET) on August 6. The panel includes NFID Medical Director Robert H. Hopkins Jr., MD; Coalition for Trust in Health & Science Executive Director Erin O’Malley; and NFID Director Jean-Venable (Kelly) R. Goode, PharmD, professor and director of the Community-Based Pharmacy Residency Program at Virginia Commonwealth University. Speakers will discuss the vaccine-preventable disease burden in the United States, strategies to identify mis- and disinformation, and implement practical communication strategies to help build trust with patients and caregivers and increase vaccine confidence. Virtual: Register for Immunize.org Website Office Hours. Ask questions and learn about the “Official Guidance” (state resources) web section on Immunize.org on August 6 at 4:00 p.m. (ET) or August 7 at 12:00 p.m. (ET). Recorded sessions archived.
To learn simple tips and tricks for using our website efficiently, please register for our next set of Website Office Hours on Wednesday, August 6 at 4:00 p.m. (ET) or Thursday, August 7 at 12:00 p.m. (ET). The same content will be covered in both sessions. The archive of previous Website Office Hours content is posted at Immunize.org’s "Webinars & Videos" page. These archived programs include Ask the Experts; Clinical Resources; Vaccine Information Statements (VISs); Affiliated Websites; Images, Webinars, Videos, & Social Media; Let's Get Real About Vaccines Website; News & Updates; Official Guidance Part 1 & 2; Publication Archives, Vaccine Timeline, & About Us; Travel Vaccines, Vaccine Confidence, & Addressing Concerns; and Vaccines A–Z. Mark your calendar for future Immunize.org Website Office Hours. For more upcoming events, visit our Calendar of Events. |
|||||||||||
|
